Collegium Internationale Neuro-Psychopharmacologicum 23rd Congress (CROSBI ID 498426)
Prilog sa skupa u zborniku | stručni rad
Podaci o odgovornosti
Pivac, Nela ; Muck-Šeler, Dorotea
engleski
Collegium Internationale Neuro-Psychopharmacologicum 23rd Congress
The 23rd Collegium Internationale Neuro-Psychopharmacologicum Congress intended to combine the efforts of the psychiatrists and basic scientists, clinicians and researchers, to incorporate preclinical knowledge of the drug effects and neurobiological basis of mental disorders into the clinical praxis, to extrapolate and evaluate the data from in vitro to in vivo models, into understanding of the biological basis of pathophysiology, and treatment and therapy of psychiatric disorders, and to achieve total remission in patients and to reduce the occurrence of adverse effects of neurotropic drugs.
neurogenesis; escitalopram; bipolar disorders; inhibition of 5-HT and NE
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
1-5.
2002.
objavljeno
Podaci o matičnoj publikaciji
The investigational drugs database IDDB Meeting Report RF 457312 ; RF457313
Croasdell, Gary
London : Delhi: Thomson Scientific Limited
Podaci o skupu
Collegium Internationale Neuro-Psychopharmacologicum Congress (23 ; 2002)
predavanje
23.06.2002-27.06.2002
Montréal, Kanada